摘要
目的探讨末端瓣膜式高压注射型经外周静脉置入中心静脉导管(Power PICC SOLO)在肿瘤患者中的应用效果。方法选取我院肿瘤诊疗中心2017年4月至2017年7月经外周静脉置入中心静脉导管(PICC)的110例患者为研究对象,按照置管方式的不同分为2组,每组各55例。其中观察组行Power PICC SOLO置管,对照组行耐高压注射型PICC(Power PICC)置管,比较2组患者导管留置期间并发症发生率。结果观察组血栓[1例(1.8%)]和堵管发生率[0(0%)]低于对照组[分别为6例(10.9%)、3例(5.4%)],差异有统计学意义(P<0.05)。结论采用Power PICC SOLO并发症少,可减轻护理工作量,且对于凝血功能障碍的患者具有突出优势,值得临床推广。
To evaluate the therapeutic effects of Power PICC saline only locking option(SOLO)catheter in tumor patients.One hundred and ten tumor patients admitted into the Tumor Diagnosis and Treatment Center of the hospital from April 2017 to July 2017 were recruited as research subjects.In accordance with different ways of catheterization,the patients were divided into two groups,each consisting of 55 patients.The observation group underwent Power PICC SOLO catheterization,while the control group had Power PICC catheterization.Then,incidence of complications during catheterization was compared between the 2 groups.There was only one case of thrombosis(1.8%)and no case of vessel obstruction(0%),which were significantly lower than those of the control group[respectively 6(10.9%)and 3 cases(5.4%)],and there was statistical significance when comparisons were made between them(P<0.05).Power PICC SOLO catheter had the advantages of fewer complications,lighter nursing load,and it could meet treatment needs during different stages of treatment.More importantly,it was beneficial to those patients with blood coagulation disorder
作者
蔡昌兰
陈杉杉
李琼
赵明霞
Cai Changlan;Chen Shanshan;Li Qiong;Zhao Mingxia(Tumor Diagnosis and Treatment Center,Navy General Hospital,Beijing 100048,China)
出处
《海军医学杂志》
2018年第1期70-71,98,共3页
Journal of Navy Medicine
基金
海军总医院护理创新培育基金(HLCX-07)
